A groundbreaking study has shed light on the complex interactions between dystrophin, a protein critical to muscle stability, and its partner protein, dystrobrevin, offering new pathways for understanding and treating Duchenne Muscular Dystrophy (DMD).
Categories
Recent Posts
- Izzy Camilleri Merges High Fashion and Adaptive Clothing Design
- My late brother was my greatest teacher, in life and Duchenne
- LGMD gene therapy gets FDA orphan drug designation
- Capricor plans Deramiocel resubmission to the FDA, pursuing both cardiac and skeletal muscle indications in Duchenne
- MDA Ambassador Guest Blog: Life Lessons on My Journey with Becker Muscular Dystrophy